-

P&G Appoints Ashley McEvoy to Board of Directors

Appointment Deepens Board Expertise in Global Consumer Health Care

CINCINNATI--(BUSINESS WIRE)--The Procter & Gamble Company (NYSE:PG) today announced that its Board of Directors has appointed Ashley McEvoy, former Executive Vice President, Worldwide Chairman of MedTech at Johnson & Johnson, to the Company’s Board of Directors, effective December 12, 2023.

During her nearly three-decade career with Johnson & Johnson, Ms. McEvoy most recently led its $27 billion Medical Devices segment, which is the world’s second-largest medical devices business. In this capacity she spearheaded efforts to develop integrated, digitized solutions to improve outcomes for millions of people around the world. This includes having led the business’ entrance into telehealth, robotics, and digital surgery, and deployment of more than $20 billion in M&A activity in recent years to grow the business portfolio.

She previously served as Johnson & Johnson’s Group Chairman, Consumer Medical Devices; Group Chairman, Vision Care; Worldwide President, Ethicon Products; President, McNeil Consumer Healthcare; and various management, marketing and brand management roles in OTC and other consumer health care.

“Ashley’s transformative leadership, track record of innovation and breadth of experience in serving consumers and growing markets will be an asset to P&G. Her expertise will further strengthen the capability of our Board as we improve the lives of consumers around the world,” said Jon Moeller, P&G’s Chairman of the Board, President and Chief Executive Officer.

About Procter & Gamble

P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit https://www.pg.com for the latest news and information about P&G and its brands. For other P&G news, visit us at https://www.pg.com/news.

Category: PG-IR

Contacts

P&G Media Contacts:
Jennifer Corso
corso.jj@pg.com

Procter & Gamble

NYSE:PG

Release Versions

Contacts

P&G Media Contacts:
Jennifer Corso
corso.jj@pg.com

More News From Procter & Gamble

P&G Recommends Stockholders Reject April 7 Mini-Tender Offer by Potemkin Limited

CINCINNATI--(BUSINESS WIRE)--The Procter & Gamble Company (NYSE:PG) today announced that it has been notified of an unsolicited “mini-tender” offer by Potemkin Limited (Potemkin) to purchase up to 100,000 shares of the Company’s common stock at a price of $100.00 per share. The $100.00 per share offer price represents an approximately 30% discount to the closing price of $142.77 on April 6, 2026, the last trading day prior to the date of the offer. P&G shareholders who tender their shar...

P&G Declares Dividend Increase for April 2026

CINCINNATI--(BUSINESS WIRE)--The Board of Directors of The Procter & Gamble Company (NYSE:PG) declared an increased quarterly dividend of $1.0885 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after May 15, 2026 to Common Stock shareowners of record at the close of business on April 24, 2026, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareowners of record at the start of busine...

P&G Recommends Stockholders Reject Mini-Tender Offer by Potemkin Limited

CINCINNATI--(BUSINESS WIRE)--The Procter & Gamble Company (NYSE:PG) today announced that it has been notified of an unsolicited “mini-tender” offer by Potemkin Limited (Potemkin) to purchase up to 10,000 shares of the Company’s common stock at a price of $100.00 per share. The $100.00 per share offer price represents an approximately 30% discount to the closing price of $143.16 on March 24, 2026, the last trading day prior to the date of the offer. P&G shareholders who tender their shar...
Back to Newsroom